Jyothikumar, Vinod and Klanbut, Khanungkan and Tiong, John and Roxburgh, James S. and Hunter, Iain S. and Smith, Terry K. and Herron, Paul R. (2012) Cardiolipin synthase is required for Streptomyces coelicolor morphogenesis. Molecular Microbiology, 84 (1). pp. 181-197. ISSN 0950-382XFull text not available in this repository. (Request a copy from the Strathclyde author)
The fluid mosaic model has recently been amended to account for the existence of membrane domains enriched in certain phospholipids. In rod-shaped bacteria, the anionic phospholipid cardiolipin is enriched at the cell poles but its role in the morphogenesis of the filamentous bacterium Streptomyces coelicolor is unknown. It was impossible to delete clsA (cardiolipin synthase; SCO1389) unless complemented by a second copy of clsA elsewhere in the chromosome. When placed under the control of an inducible promoter, clsA expression, phospholipid profile and morphogenesis became inducer dependent. TLC analysis of phospholipid showed altered profiles upon depletion of clsA expression. Analysis of cardiolipin by mass spectrometry showed two distinct cardiolipin envelopes that reflected differences in acyl chain length; the level of the larger cardiolipin envelope was reduced in concert with clsA expression. ClsA-EGFP did not localize to specific locations, but cardiolipin itself showed enrichment at hyphal tips, branch points and anucleate regions. Quantitative analysis of hyphal dimensions showed that the mycelial architecture and the erection of aerial hyphae were affected by the expression of clsA. Overexpression of clsA resulted in weakened hyphal tips, misshaped aerial hyphae and anucleate spores and demonstrates that cardiolipin synthesis is a requirement for morphogenesis in Streptomyces.
|Keywords:||fluid mosaic model, phospholipids, Streptomyces coelicolor, mycelial architecture, Pharmacy and materia medica, Molecular Biology, Microbiology|
|Subjects:||Medicine > Pharmacy and materia medica|
|Department:||Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences|
|Depositing user:||Pure Administrator|
|Date Deposited:||10 Apr 2012 10:21|
|Last modified:||22 Mar 2017 12:04|